Before increasing your GLP-1 dose, check in on your nutrition, hydration, and side effects. Small adjustments now can make the next dose easier and more effective.#GLP1Tips #WeightLossJourney #ObesityMedicine #SmartWeightLoss  #GLP1Support #SustainableWeightLoss #zepbound #wegovy

Stabilize blood sugar with protein, fiber, and color—and everything gets easier. Less hunger. Better energy. Sustainable weight loss.

Read more: www.marmean.com/blog/insulin-resistance-diet

#insulinresistance #weightlossforwomen #glp1 #metabolichealth  #obesitymedicine #sustainableweightloss

Throwback to speaking at the ACS Clinical Congress in Chicago.
Photo courtesy: American College of Surgeons.

#BariatricSurgery #ObesityMedicine #WeightLossSurgery #MetabolicHealth #HealthcareEducation #ObesityAwareness #PatientCare #MedicalScience #HealthJourney #DrMonaMisra

Weight Loss is Good, but Maybe Not for Your Bones There's a downside to weight loss that many older adults may not know about: It can speed bone loss. Weight-bearing exercise can help.

Weight Loss is Good, but Not for Your Bones
Many older adults may not know that losing weight speeds bone loss. Weight-bearing exercise or a weighted vest can help. bit.ly/4bAKky7 #seniors #glp1weightloss #bonehealth #BoneDensity #obesitymedicine #agingwell @wakeforest.bsky.social #boneloss #aging

We call it “failed bariatric surgery” when it’s untreated obesity.

Only ~14% of post‑bariatric pts ever get a GLP‑1, despite data showing ~8–12% extra loss when we actually use them.

Are you offering meds or just talking revision? Read more at docslounge.substack.com

#PrimaryCare #ObesityMedicine

Hit a weight loss plateau? You're not alone. Here's some ways to help break through—whether you're on GLP-1s or not.

Read more: www.marmean.com/blog/how-i-help-patients-break-through-a-weight-loss-plateau

#GLP1 #Ozempic #Wegovy #Zepbound #Mounjaro #WeightLoss #ObesityMedicine

Do gene-based therapies really represent the next frontier in #ObesityMedicine as Daniel Gilbert writes in @washingtonpost.com? Let's brush away the hype to see what the science is saying.
conscienhealth.org/2026/01/25/w...

Save the Date — November 1!
4th AMWA episode of Breakthrough Women in Science & Medicine premieres on PBS, featuring Dr. Fatima Cody Stanford, a global leader transforming how we understand and treat obesity.

#BreakthroughWomen #WomenInMedicine #PBS #FatimaCodyStanford #ObesityMedicine

If you thought enthusiasm for investing in #ObesityMedicine development was waning, think again. Roche and Pfizer are making big commitments and putting big money on the table.
conscienhealth.org/2025/09/big-...

Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction This study evaluates the effectiveness and safety of semaglutide and tirzepatide in patients with cardiometabolic heart failure with preserved ejection fraction in clinical practice.

"Patients initiating semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure or all-cause mortality compared with sitagliptin...In a head-to-head comparison, tirzepatide showed no meaningful benefit over semaglutide." #medsky #obesitymedicine bit.ly/41xqRcq

Yesterday, #Wegovy became the first #ObesityMedicine with an indication for #MASH. This is a big deal because it supports the understanding that treating obesity is all about long-term gains in health, not just short-term weight loss.
conscienhealth.org/2025/08/wego...

Three new papers in @thelancet.com et offer the clearest picture yet of #amycretin and the reasons for optimism that this new #ObesityMedicine can help to lift @novonordisk.bsky.social from its funk.
conscienhealth.org/2025/07/will...

⚖️ In the July issue of #SGIMForum, Dr. Chelsea Pearson explores the urgent need for affordable, equitable obesity treatment—and what clinicians can do to advocate for change. #ObesityMedicine #HealthEquity #PolicyReform

🔗 buff.ly/fmLcho6

@cpearson86.bsky.social

New Obesity Definition Raises the Number Who Have It About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

European Association for the Study of Obesity's new framework increases the estimate of those who are #obese.
Story via @medscape.com @miriametucker.bsky.social

#MedSky #EndoSky #nutrition #weight #primarycare #FPSky #obesitymedicine

Let’s start with a few basics. Expensive bunk is not a substitute for actual healthcare. And #GlucoseMonitoring (in the absence of diabetes) is no substitute for #ObesityMedicine. Not even close.
conscienhealth.org/2025/06/no-g...

Bariatric Surgery Beats GLP-1 RAs for Sustained Weight Loss Bariatric surgery is associated with a significantly greater long-term weight loss than treatment with GLP-1 receptor agonists, a new head-to-head real-world study finds.

www.medscape.com/viewarticle/...

#medsky #obesitymedicine

Mental health + GLP-1s = better outcomes. Dr. Jennalee Wooldridge’s #ADA2025 message: screen first, support behavior change, sustain weight loss.
@amdiabetesassn.bsky.social
#ADASciSessions #ObesityMedicine #GLP1 #MentalHealthSupport

Don’t Overlook First-Gen Anti-Obesity Medications Obesity specialists say first-generation anti-obesity medications often get a ‘bad wrap,’ but these drugs can be effective and cost-friendly for many patients.

www.medscape.com/viewarticle/...

#obesitymedicine #medsky #endosky

SURMOUNT-5: for obesity but w/o diabetes, tirzepatide superior to semaglutide wrt reduction in body weight and waist circumference at wk 72. N=751 meant % weight change -20.2% vs -13.7% (P<.001). High rates of GI AEs w/ both agents. #medsky #obesitymedicine

Have you seen this petition yet? Stop CVS Caremark’s Zepbound Ban — Restore Coverage of the Superior Obesity Medication

Cutting off people from an evidence-based superior treatment, and with only TWO months to pivot is cruel to patients and an awful abrogation of medical decision making. #Zepbound #tirzepatide #caremark #CVS #GLP1 #obesitymedicine #medsky

chng.it/6LwJG9kXTL

I quit Ozempic and embraced feeling healthy over striving for thinness Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% of people using GLP-1 drugs for weight loss quit within a year.

www.npr.org/2025/04/24/n...

#medsky #glp1s #obesitymedicine

Dr. Jeni Sprague offers a must-hear message: language matters when treating pediatric obesity. She breaks down med options (Topiramate, Phentermine), warns against compound GLP-1s, and urges clinicians to be mindful of stigma. #PedsEndo #ObesityMedicine #WeightBias

open.spotify.com/episode/4WKf...

#CardioSky #MedSky #ObesityMedicine #GLP1ra

Discontinuing glucagon‐like peptide‐1 receptor agonists and body habitus: A systematic review and meta‐analysis Research on Glucagon-like peptide 1 receptor agonist (GLP-1RA) has mainly focused on the efficacy of weight loss and not the long-term efficacy of weight loss maintenance. This systematic review and...

manuscript: onlinelibrary.wiley.com/doi/10.1111/...

#GLP1 #WeightLossResearch #ObesityMedicine #MetaAnalysis #Endocrinology #MedicalResearch #EvidenceBasedMedicine

Obesity Management Learning Hub | ACP Online This comprehensive, up-to-date learning series provides practical guidance to support physicians and their teams in treating patients with obesity. Learn more.

www.acponline.org/clinical-inf...

#obesitymedicine #medsky #internalmedicine

Lecture highlights II from @acpimphysicians.bsky.social #IM2025 in NOLA

#endosky #hospitalmedicine #internalmedicine #medsky #meded #nutrition #obesitymedicine

So.... If they take away GLP1-RAs... Women will never vote for Republicans again. Shitttttt Utah might even flip blue. #maha #glps #dietculture #toxic #obesitymedicine #nursepractitioner

A (Reluctant) Look at the Data on Obesity and Sexuality Obesity may complicate sex, but pleasure’s still in play, writes Pebble Kranz, MD

www.medscape.com/viewarticle/...

#medsky #obesitymedicine #sexualhealth #healthateverysize